Sunstone Therapies Announces Expansion of Innovative Dyad Study Rockville, Maryland, October 03, 2023 – Sunstone Therapies, a leader in the delivery of psychedelic-assisted therapy in the medical setting and the development and execution of clinical trials, today announces the expansion of its MDMA-assisted Dyad Study to include 20 dyads (pairs of participants). The study is being funded in part…


Previous articlePT447 – Exile & Ecstasy: The Intersection of Jewish Culture, Spirituality, and Psychedelics
Next articleGratitude Revealed: Film Screening and Q&A with Director Louie Schwartzberg